NCT03389750View on ClinicalTrials.gov

A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

June 15, 2022

Study Completion Date

June 28, 2023

Conditions
Opioid Use Disorder
Interventions
DRUG

Intravenous Challenge Drug

Intravenous administration of opioid drugs (oxycodone, oxymorphone, hydromorphone), for the purpose of comparison of their abuse potential among each other, and in comparison to placebo (saline).

Trial Locations (2)

10032

New York State Psychiatric Institute in the Division on Substance Use Disorders, New York

40508

University of Kentucky, Lexington

All Listed Sponsors
collaborator

University of Kentucky

OTHER

lead

New York State Psychiatric Institute

OTHER

NCT03389750 - A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. | Biotech Hunter | Biotech Hunter